hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased peripheral resistance - Hypertension often results from the narrowing of blood vessels, which increases the resistance the heart must overcome to pump blood, elevating blood pressure levels.

• Secondary mechanism: Excessive sodium retention - The kidneys may retain more sodium than necessary, leading to increased blood volume and pressure against vessel walls, contributing to sustained high blood pressure.

• Key complication: Organ damage - Prolonged hypertension can strain the heart and damage blood vessels, increasing the risk of critical conditions such as heart disease, stroke, and kidney failure.

Patient Profile

Demographics:

55 years old, male, accountant

History:

• Key past medical history: Hypertension diagnosed 5 years ago, hyperlipidemia

• Current medications: Lisinopril 20 mg daily, Atorvastatin 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Frequent headaches and dizziness

• Key symptoms: Persistent fatigue, occasional chest discomfort, blurred vision

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial presentation, further diagnostic tests were conducted to assess the extent of organ involvement due to the patient's uncontrolled hypertension. A comprehensive metabolic panel revealed elevated creatinine levels at 1.8 mg/dL, indicating possible kidney impairment, as the normal range for creatinine is generally 0.6 to 1.2 mg/dL. Additionally, a urinalysis showed microalbuminuria, with albumin levels measuring 45 mg/g creatinine, suggesting early signs of kidney damage. These findings are concerning, given the patient's history of hypertension and hyperlipidemia, and suggest that the kidneys are becoming progressively affected by the sustained high blood pressure.

An echocardiogram was also performed to evaluate cardiac function. The results showed left ventricular hypertrophy (LVH), a common complication of long-standing hypertension that occurs as the heart muscle thickens to cope with increased workload. Although the ejection fraction was within normal limits at 55%, the presence of LVH signals that the patient is at increased risk for further cardiac complications, such as heart failure or arrhythmias. These diagnostic results underscore the need for a more aggressive management strategy to prevent further organ damage and stabilize the patient's condition.

These findings prompt a reevaluation of the current treatment regimen. The persistence of high blood pressure despite medication suggests potential issues with adherence, drug resistance, or lifestyle factors such as diet and physical activity. The healthcare team must consider intensifying antihypertensive therapy, possibly adding a diuretic to address sodium retention, and providing comprehensive lifestyle counseling. Continual monitoring of renal and cardiac function will be essential as part of the management plan to prevent further deterioration and improve the patient's quality of life.

Section 2

Change in Patient Status:

Two weeks following the adjustment of the patient's treatment regimen to include a diuretic and intensified lifestyle counseling, there have been notable changes in the patient's status. The patient reports experiencing increased fatigue and occasional dizziness, particularly when moving from a sitting to a standing position. These symptoms suggest potential orthostatic hypotension, a common side effect when initiating or adjusting antihypertensive therapy, particularly with the addition of diuretics.

Upon examination, the patient's blood pressure has decreased to an average of 130/85 mmHg, which is an improvement from previous readings but still requires ongoing management to reach optimal levels. However, the heart rate has increased to 95 beats per minute, up from a baseline of 75, possibly indicating a compensatory response to the reduced blood pressure or side effects from the medication. Laboratory tests indicate that while serum electrolytes remain within normal limits, there is a slight decrease in potassium levels to 3.4 mEq/L, which is at the lower end of the normal range and requires monitoring due to the risk of hypokalemia associated with diuretic use.

These developments necessitate a careful reassessment of the patient's current treatment plan. The healthcare team must balance the need to achieve better blood pressure control with the prevention of adverse effects, such as electrolyte imbalances and orthostatic symptoms. Adjustments to medication doses or the addition of potassium supplements may be considered. Furthermore, the patient should be educated on recognizing symptoms of low blood pressure and maintaining adequate hydration and nutritional intake. Continual evaluation and close follow-up will be crucial to ensure stabilization and to prevent any new complications from arising.

Section 3

Following the initial adjustments and the presentation of symptoms suggestive of orthostatic hypotension, the healthcare team decided to implement a more frequent monitoring regimen to capture any further fluctuations in the patient’s condition. During a routine follow-up visit, the patient reported a persistent dry cough and noted a slight swelling in the ankles by the end of the day. On examination, the blood pressure readings showed further improvement, averaging 125/80 mmHg, but the heart rate persisted at around 95 beats per minute. The physical assessment confirmed mild peripheral edema, and auscultation revealed clear lung sounds, ruling out fluid overload but warranting further exploration of the cough.

New diagnostic tests were ordered, including a repeat serum electrolyte panel and a chest X-ray to evaluate the cough's etiology and exclude any cardiac-related causes for the edema. The lab results showed a further decrement in potassium levels to 3.2 mEq/L, reinforcing the concern for hypokalemia. Additionally, the chest X-ray was unremarkable, indicating that the cough might be a side effect of the current medication regimen, possibly related to the ACE inhibitor in use.

In light of these findings, the clinical team began discussing potential modifications, such as switching from an ACE inhibitor to an angiotensin II receptor blocker (ARB) to alleviate the cough while managing blood pressure effectively. They also considered initiating a potassium-sparing diuretic or supplement to address the electrolyte imbalance. The patient was advised on dietary modifications to increase potassium intake naturally and educated about the importance of continuing to monitor symptoms closely. These interventions aimed to fine-tune the treatment plan, ensuring optimal blood pressure control while minimizing adverse effects, setting the stage for the next phase of the patient's therapeutic journey.

Section 4

Two weeks following the adjustment in the medication regimen, which included switching from an ACE inhibitor to an ARB and the addition of a potassium-sparing diuretic, the patient returned for a follow-up visit. The patient reported a significant reduction in coughing episodes, indicating a positive response to the change in medication. However, they expressed new concerns about experiencing occasional palpitations and increased fatigue. The clinical team noted that the patient's blood pressure remained stable, averaging 122/78 mmHg, but the heart rate had increased slightly to 98 beats per minute. Physical examination revealed the peripheral edema had not worsened but persisted mildly in the ankles.

A repeat serum electrolyte panel was conducted, revealing a slight improvement in potassium levels, now measuring at 3.5 mEq/L, suggesting a positive response to both the dietary modifications and the potassium-sparing diuretic. Despite these improvements, the patient's new symptoms prompted further evaluation to rule out other potential complications. An electrocardiogram (ECG) was ordered to assess the cause of the palpitations and ensure there were no underlying arrhythmias contributing to the patient's symptoms.

The ECG results showed occasional premature ventricular contractions (PVCs), which could explain the sensation of palpitations. While these findings were not immediately concerning, the clinical team decided to monitor the patient more closely, considering that frequent PVCs might necessitate additional intervention. The patient's fatigue was addressed through a comprehensive review of lifestyle factors, including sleep hygiene, diet, and physical activity levels, to ensure they were not contributing to the current symptoms. This assessment and intervention plan aimed to maintain the patient's blood pressure control while addressing the new symptoms, setting the stage for continued monitoring and potential future adjustments in therapy.

Section 5

Two weeks after the initial follow-up visit, the patient returned to the clinic with new complications. They reported experiencing worsening fatigue and occasional dizziness, particularly upon standing, which raised concerns about potential orthostatic hypotension. During this visit, the clinical team conducted a thorough assessment, noting that the patient appeared more lethargic than during previous evaluations. Vital signs showed a stable blood pressure of 120/76 mmHg while seated, but upon standing, the blood pressure dropped to 105/68 mmHg, confirming the presence of orthostatic changes. The heart rate remained elevated, measuring at 102 beats per minute.

To further evaluate the patient's condition, additional diagnostic tests were ordered, including a comprehensive metabolic panel and a repeat ECG. The metabolic panel revealed a slight decrease in sodium levels, now at 133 mEq/L, which could be contributing to the dizziness and fatigue. The repeat ECG showed an increase in the frequency of premature ventricular contractions, now occurring in a pattern that suggested increased cardiac irritability. These findings prompted the clinical team to consider the possibility of an adverse interaction between the potassium-sparing diuretic and the patient's current electrolyte balance, potentially exacerbating both the orthostatic hypotension and the cardiac symptoms.

Given these developments, the clinical team decided to adjust the patient's medication regimen. The potassium-sparing diuretic was reduced, and a low-dose beta-blocker was introduced to manage the elevated heart rate and reduce the frequency of PVCs. Additionally, the patient was counseled on strategies to manage orthostatic hypotension, including rising slowly from seated positions and increasing fluid and salt intake within dietary guidelines. This approach aimed to stabilize the patient's cardiovascular status while addressing the new complications, setting the stage for another follow-up to assess the response to these interventions and determine the need for further adjustments.